Is Baxter International Inc (BAX) overvalued? · rev $2.75B
Baxter International Inc (BAX) is a medical instruments & supplies company listed on NYSE.
This page asks whether Baxter International Inc (BAX) looks expensive on cached numbers — not a short thesis.
Latest reported BAX revenue for 2024-12-31 was $2.75B. Net income was -$510.0M. Revenue was up 2.0% from 2024-09-30 to 2024-12-31. BAX currently screens at market cap $10.01B.
BAX currently screens at market cap $10.01B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next BAX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the BAX stock page for the full model, not this heading.
Not investment advice.